Alisertib (MLN8237) Mechanism of Action: Aurora A Kinase Inhibition in Breast Cancer Cell Research

Alisertib (MLN8237) MOA:Targeting Aurora A Kinase/Cell Cycle Pathway for Metastatic Breast Cancer

🎯 check Alisertib (MLN8237) product page

Alisertib (MLN8237) is a potent and highly selective Aurora A kinase inhibitor. It affects DNA damage, PI3K/AKT, and cGAS/STING signaling pathways, by blocking AURKA phosphorylation and inducing G2/M cell cycle arrest, thereby inhibiting tumor cell proliferation and promoting apoptosis and senescence.

Primary Applications and Mechanism of Action